Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Which rewards card is better for travel? Explore options to maximize your travel benefits and choose the right card for you.
22,786 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A single dollar past an IRMAA threshold can trigger steep Medicare premium hikes for retirees, potentially totaling t...
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
SpaceX aims for a $1.75 trillion IPO, triggering a fierce debate among analysts about whether growth, cash flow, and ...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
ADA slumped about 40% in June, trading near $0.16 as Bitcoin stayed near $60,000. Analysts say zero price is unlikely...
Bitcoin, Ethereum, and XRP flashed potential buy signals after a wide market drop, according to on-chain analytics. A...
Tech-led gains push major indices higher on June 9, 2026, with the S&P 500 and Nasdaq leading the rally as investors ...
IBM is shifting to a software-led model with accelerating cash flow and a higher dividend, signaling a durable, AI-ti...
Retail prices rose in May, pushing inflation to a multi-year high as gas costs surged. The data raise questions for h...
As inflation stays stubborn, the latest CPI data point toward a larger COLA for 2027, though 2026 benefits are alread...
If SpaceX goes public, the market could shift toward a new era of space commerce. This guide breaks down the three cr...